Inogen's new management and strategy are yielding results, with better-than-expected 2024 performance and a more stable base from which to keep growing the B2B business. Despite weak DTC sales, strong ...
Inogen’s share price has performed poorly since I rated the stock a Buy in July 2023, and for good reason. Another round of senior executive changes combined with a questionable acquisition has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback